Literature DB >> 7644393

Is this patient fit for thoracotomy and resection of lung tissue?

S D Thomas1, P D Berry, G N Russell.   

Abstract

Central to risk assessment for lung resection is the fact that surgery offers the only chance of long-term survival and cure in non-small carcinoma of the lung. The challenge is, therefore, to offer surgery to as many patients as possible, whilst avoiding the risk of death from postoperative respiratory failure. Risk assessment is based on careful evaluation of the patient's existing cardiac and respiratory disease. The use of a cardiac risk index, such as that described by Detsky, will ensure that cardiac risk factors are recognised and, where possible, ameliorated prior to surgery. Pre-existing respiratory disease may be assessed by arterial blood gas analysis, exercise testing, whole and regional lung function tests. Criteria based on these tests have been proposed to aid patient selection prior to lung resection. However, these criteria take no account of the beneficial influence on outcome of modern anaesthesia and postoperative care. The elimination of postoperative pain, along with techniques such as minitracheostomy and incentive spirometry have allowed surgery to be offered to many patients who would have been deemed unsuitable by standard criteria. Patients with potentially resectable lung cancer must never be arbitrarily excluded from surgery on the basis of any single criteria or test. Referral for assessment by an experienced team consisting of a thoracic physician, surgeon and anaesthetist will maximise the number of patients offered surgery for this otherwise incurable disease.

Entities:  

Mesh:

Year:  1995        PMID: 7644393      PMCID: PMC2398128          DOI: 10.1136/pgmj.71.836.331

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  28 in total

1.  Assessment of operative risk in thoracic surgery.

Authors:  C MITTMAN
Journal:  Am Rev Respir Dis       Date:  1961-08

2.  Elective pneumonectomy: factors associated with morbidity and operative mortality.

Authors:  R L Patel; E R Townsend; S W Fountain
Journal:  Ann Thorac Surg       Date:  1992-07       Impact factor: 4.330

Review 3.  Preoperative cardiopulmonary exercise testing: determining the limit to exercise and predicting outcome after thoracotomy.

Authors:  R S Fishman; D M Systrom
Journal:  J Cardiothorac Vasc Anesth       Date:  1991-12       Impact factor: 2.628

4.  Efficacy of continuous extrapleural intercostal nerve block on post-thoracotomy pain and pulmonary mechanics.

Authors:  S Sabanathan; A J Mearns; P J Bickford Smith; J Eng; R G Berrisford; S R Bibby; M R Majid
Journal:  Br J Surg       Date:  1990-02       Impact factor: 6.939

5.  Regional lung function after pneumonectomy.

Authors:  D R Hall
Journal:  Thorax       Date:  1974-07       Impact factor: 9.139

6.  Ventilatory capacity in chronic bronchitis in relation to carbon dioxide retention.

Authors:  J J Segall; B A Butterworth
Journal:  Scand J Respir Dis       Date:  1966

7.  Right ventricular dysfunction after major pulmonary resection.

Authors:  M Okada; T Ota; M Okada; H Matsuda; K Okada; N Ishii
Journal:  J Thorac Cardiovasc Surg       Date:  1994-09       Impact factor: 5.209

8.  Determination of operability in candidates who undergo lung resection for bronchogenic carcinoma.

Authors:  T P Murphy; M T Casey
Journal:  Can J Surg       Date:  1990-12       Impact factor: 2.089

9.  Graded exercise testing and postthoracotomy complications.

Authors:  P G Boysen; C A Clark; A J Block
Journal:  J Cardiothorac Anesth       Date:  1990-02

10.  Pulmonary function evaluation of the lung resection candidate: a prospective study.

Authors:  G N Olsen; A J Block; E W Swenson; J R Castle; J W Wynne
Journal:  Am Rev Respir Dis       Date:  1975-04
View more
  1 in total

1.  Evaluation of left and right ventricular myocardial function after lung resection using speckle tracking echocardiography.

Authors:  Zhenhua Wang; Jianjun Yuan; Wen Chu; Yuhong Kou; Xijun Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.